...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Targeting formyl peptide receptors to facilitate the resolution of inflammation
【24h】

Targeting formyl peptide receptors to facilitate the resolution of inflammation

机译:靶向甲醛肽受体以促进炎症的分辨率

获取原文
获取原文并翻译 | 示例
           

摘要

The formyl peptide receptors (FPRs) are G protein coupled receptors that recognize a broad range of structurally distinct pathogen and danger-associated molecular patterns and mediate host defense to infection and tissue injury. It became evident that the cellular distribution and biological functions of FPRs extend beyond myeloid cells and governing their activation and trafficking. In recent years, significant progress has been made to position FPRs at check points that control the resolution of inflammation, tissue repair and return to homeostasis. Accumulating data indicate a role for FPRs in an ever-increasing range of human diseases, including atherosclerosis, chronic obstructive pulmonary disease, asthma, autoimmune diseases and cancer, in which dysregulated or defective resolution are increasingly recognized as critical component of the pathogenesis. This review summarizes recent advances on how FPRs recognize distinct ligands and integrate opposing cues to govern various responses and will discuss how this knowledge could be harnessed for developing novel therapeutic strategies to counter inflammation that underlies many human diseases.
机译:甲醛肽受体(FPRS)是G蛋白偶联受体,其识别广泛的结构性不同的病原体和危险相关的分子模式,并介导宿主防御,以对感染和组织损伤进行宿主防御。显而易见的是,FPRS的细胞分布和生物学功能延伸到骨髓细胞之外并控制其激活和贩运。近年来,在控制炎症,组织修复和恢复到稳态的检查点时,已经提出了重大进展。累积数据表明FPRS在不断增加的人类疾病范围内的作用,包括动脉粥样硬化,慢性阻塞性肺病,哮喘,自身免疫疾病和癌症,其中具有多疑或有缺陷的分辨率越来越被认为是发病机制的关键组分。本综述总结了近期FPRS如何认识到不同配体的概况,并将反对线索整合到管理各种响应,并将讨论如何利用这种知识,以便制定新的治疗策略,以对抗许多人类疾病的抗炎症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号